ZANTAC HAS LOW LEVELS OF A CANCER-CAUSING CHEMICAL, THE F.D.A. SAYS | WHAT REALLY HAPPENED

ZANTAC HAS LOW LEVELS OF A CANCER-CAUSING CHEMICAL, THE F.D.A. SAYS

SOURCE: NYTIMES.COM

The Food and Drug Administration said on Friday that it had detected low levels of a cancer-causing contaminant in samples of heartburn medicines containing the drug commonly known as Zantac.

It was advising patients who take over-the-counter versions to consider switching to a different medication.

But no recalls have been initiated, and the agency said patients who take prescription versions of the drug, known as ranitidine, should consult with their doctors before stopping. The European Medicines Agency is also looking into the issue.

Webmaster's Commentary: 

WOW, just great!

And one has to wonder just how long the FDA knew about this, before they created this announcement?!? (and dumped on a Friday, of course, when fewer people were likely to read it)

This is yet one more example of the FDA allowing private profits to trump public health responsibility.

One has to wonder just how many members of the FDA have stocks in the firm that produces Zantac (it's Sanofi Consumer Healthcare, making $41.8 billion annually BTW).

Information like this is power for the end consumer; you have to check the risk/benefit ratio of any medication you may be taking, or have been subscribed.

Comments

SHARE THIS ARTICLE WITH YOUR SOCIAL MEDIA